Company Biodexa Pharmaceuticals Plc London S.E.
Equities
BDRX
GB00BNGF1L75
Biotechnology & Medical Research
Business Summary
Number of employees: 21
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pipeline Research and Development
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -44.99% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Belgium
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -44.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Stamp
CEO | Chief Executive Officer | 62 | 19-09-08 |
Dan Palmer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 44 | 21-07-10 | |
Steve Ellul
PRN | Corporate Officer/Principal | - | 22-01-31 |
Fiona Sharp
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Parker
CHM | Chairman | 65 | 22-06-19 |
Sijmen de Vries
BRD | Director/Board Member | 65 | 14-10-28 |
Stephen Stamp
CEO | Chief Executive Officer | 62 | 19-09-08 |
Simon Turton
BRD | Director/Board Member | 56 | 14-12-07 |
Ann Merchant
BRD | Director/Board Member | 59 | Dec. 30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 400 | 67,714 | 39,217 ( 57.92 %) | 0 | 57.92 % |
Company contact information
Biodexa Pharmaceuticals Plc
1 Caspian Point Caspian Way
CF10 4DQ, Cardiff
+44 29 2048 0180
http://www.midatechpharma.comGroup companies
Name | Category and Sector |
---|---|
Midatech Pharma España SL
Midatech Pharma España SL Pharmaceuticals: MajorHealth Technology Part of Biodexa Pharmaceuticals Plc, Midatech Pharma España SL is a pharmaceutical company located in Spain. The Spanish company operates in the field of oncology and other areas. |
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |